Search research articles
Contact Us
Filters
Showing results (151-160 of 175) with videos related to
Page
of 18
Sort By:
Annals of Internal Medicine
|
June 15, 1996
Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators
R T D'Aquila, M D Hughes, V A Johnson, et al.
Journal of Medicinal Chemistry
|
February 14, 1997
Novel 3'-C/N-substituted 2',3'-beta-D-dideoxynucleosides as potential chemotherapeutic agents. 1. Thymidine derivatives: synthesis, structure, and broad spectrum antiviral properties
I I Fedorov, E M Kazmina, G V Gurskaya, et al.
Journal of Medicinal Chemistry
|
October 27, 2006
Synthesis and pharmacokinetics of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 2'-C-methylcytidine
Claire Pierra, Agnès Amador, Samira Benzaria, et al.
Antimicrobial Agents and Chemotherapy
|
December 22, 1999
Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1
G M Szczech, P Furman, G R Painter, et al.
Future Medicinal Chemistry
|
October 2, 2015
Design, synthesis and antiviral evaluation of 2'-C-methyl branched guanosine pronucleotides: the discovery of IDX184, a potent liver-targeted HCV polymerase inhibitor
Gwenaëlle Sizun, Claire Pierra, Jérôme Peyronnet, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2002
Pharmacology of beta-L-thymidine and beta-L-2'-deoxycytidine in HepG2 cells and primary human hepatocytes: relevance to chemotherapeutic efficacy against hepatitis B virus
B Hernandez-Santiago, L Placidi, E Cretton-Scott, et al.
The Journal of Antimicrobial Chemotherapy
|
October 3, 2001
Prototype trial design for rapid dose selection of antiretroviral drugs: an example using emtricitabine (Coviracil)
F S Rousseau, J O Kahn, M Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 1998
Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team
B J Dezube, J H Von Roenn, J Holden-Wiltse, et al.
The Journal of Infectious Diseases
|
February 22, 2001
Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS Clinical Trials Group protocol 373
R M Gulick, L M Smeaton, R T D'Aquila, et al.
AIDS (London, England)
|
July 14, 2000
Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir
R M van Praag, G J Weverling, P Portegies, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 175) with videos related to
Sort By:
Page
of 18
Annals of Internal Medicine
|
June 15, 1996
Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators
R T D'Aquila, M D Hughes, V A Johnson, et al.
Journal of Medicinal Chemistry
|
February 14, 1997
Novel 3'-C/N-substituted 2',3'-beta-D-dideoxynucleosides as potential chemotherapeutic agents. 1. Thymidine derivatives: synthesis, structure, and broad spectrum antiviral properties
I I Fedorov, E M Kazmina, G V Gurskaya, et al.
Journal of Medicinal Chemistry
|
October 27, 2006
Synthesis and pharmacokinetics of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 2'-C-methylcytidine
Claire Pierra, Agnès Amador, Samira Benzaria, et al.
Antimicrobial Agents and Chemotherapy
|
December 22, 1999
Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1
G M Szczech, P Furman, G R Painter, et al.
Future Medicinal Chemistry
|
October 2, 2015
Design, synthesis and antiviral evaluation of 2'-C-methyl branched guanosine pronucleotides: the discovery of IDX184, a potent liver-targeted HCV polymerase inhibitor
Gwenaëlle Sizun, Claire Pierra, Jérôme Peyronnet, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2002
Pharmacology of beta-L-thymidine and beta-L-2'-deoxycytidine in HepG2 cells and primary human hepatocytes: relevance to chemotherapeutic efficacy against hepatitis B virus
B Hernandez-Santiago, L Placidi, E Cretton-Scott, et al.
The Journal of Antimicrobial Chemotherapy
|
October 3, 2001
Prototype trial design for rapid dose selection of antiretroviral drugs: an example using emtricitabine (Coviracil)
F S Rousseau, J O Kahn, M Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 1998
Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team
B J Dezube, J H Von Roenn, J Holden-Wiltse, et al.
The Journal of Infectious Diseases
|
February 22, 2001
Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS Clinical Trials Group protocol 373
R M Gulick, L M Smeaton, R T D'Aquila, et al.
AIDS (London, England)
|
July 14, 2000
Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir
R M van Praag, G J Weverling, P Portegies, et al.
Page
of 18